| 000 | 01419 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514185919.0 | ||
| 264 | 0 | _c20050103 | |
| 008 | 200501s 0 0 eng d | ||
| 022 | _a1619-7070 | ||
| 024 | 7 |
_a10.1007/s00259-004-1528-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScheidhauer, K | |
| 245 | 0 | 0 |
_aFDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions. _h[electronic resource] |
| 260 |
_bEuropean journal of nuclear medicine and molecular imaging _cJun 2004 |
||
| 300 |
_aS70-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
| 650 | 0 | 4 | _aPractice Patterns, Physicians' |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSubtraction Technique |
| 650 | 0 | 4 | _aTechnetium Tc 99m Sestamibi |
| 650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
| 700 | 1 | _aWalter, C | |
| 700 | 1 | _aSeemann, M D | |
| 773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 31 Suppl 1 _gp. S70-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-004-1528-7 _zAvailable from publisher's website |
| 999 |
_c14843259 _d14843259 |
||